BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 15389820)

  • 1. Substrates of the prostate-specific serine protease prostase/KLK4 defined by positional-scanning peptide libraries.
    Matsumura M; Bhatt AS; Andress D; Clegg N; Takayama TK; Craik CS; Nelson PS
    Prostate; 2005 Jan; 62(1):1-13. PubMed ID: 15389820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of hK4 (prostase), a prostate-specific serine protease: activation of the precursor of prostate specific antigen (pro-PSA) and single-chain urokinase-type plasminogen activator and degradation of prostatic acid phosphatase.
    Takayama TK; McMullen BA; Nelson PS; Matsumura M; Fujikawa K
    Biochemistry; 2001 Dec; 40(50):15341-8. PubMed ID: 11735417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of latent protease function of pro-hK2, but not pro-PSA, involves autoprocessing.
    Denmeade SR; Lövgren J; Khan SR; Lilja H; Isaacs JT
    Prostate; 2001 Jul; 48(2):122-6. PubMed ID: 11433422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defining the extended substrate specificity of kallikrein 1-related peptidases.
    Borgoño CA; Gavigan JA; Alves J; Bowles B; Harris JL; Sotiropoulou G; Diamandis EP
    Biol Chem; 2007 Nov; 388(11):1215-25. PubMed ID: 17976015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of positional-scanning libraries of fluorogenic peptide substrates to define the extended substrate specificity of plasmin and thrombin.
    Backes BJ; Harris JL; Leonetti F; Craik CS; Ellman JA
    Nat Biotechnol; 2000 Feb; 18(2):187-93. PubMed ID: 10657126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substrate-guided design of a potent and selective kallikrein-related peptidase inhibitor for kallikrein 4.
    Swedberg JE; Nigon LV; Reid JC; de Veer SJ; Walpole CM; Stephens CR; Walsh TP; Takayama TK; Hooper JD; Clements JA; Buckle AM; Harris JM
    Chem Biol; 2009 Jun; 16(6):633-43. PubMed ID: 19549601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epithelial-mesenchymal transition in prostate cancer and the potential role of kallikrein serine proteases.
    Lawrence MG; Veveris-Lowe TL; Whitbread AK; Nicol DL; Clements JA
    Cells Tissues Organs; 2007; 185(1-3):111-5. PubMed ID: 17587816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct progesterone receptor and indirect androgen receptor interactions with the kallikrein-related peptidase 4 gene promoter in breast and prostate cancer.
    Lai J; Myers SA; Lawrence MG; Odorico DM; Clements JA
    Mol Cancer Res; 2009 Jan; 7(1):129-41. PubMed ID: 19147544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kallikrein 4 (hK4) and prostate-specific antigen (PSA) are associated with the loss of E-cadherin and an epithelial-mesenchymal transition (EMT)-like effect in prostate cancer cells.
    Veveris-Lowe TL; Lawrence MG; Collard RL; Bui L; Herington AC; Nicol DL; Clements JA
    Endocr Relat Cancer; 2005 Sep; 12(3):631-43. PubMed ID: 16172196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kallikrein 4 is a proliferative factor that is overexpressed in prostate cancer.
    Klokk TI; Kilander A; Xi Z; Waehre H; Risberg B; Danielsen HE; Saatcioglu F
    Cancer Res; 2007 Jun; 67(11):5221-30. PubMed ID: 17545602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polyclonal antibodies against kallikrein-related peptidase 4 (KLK4): immunohistochemical assessment of KLK4 expression in healthy tissues and prostate cancer.
    Seiz L; Kotzsch M; Grebenchtchikov NI; Geurts-Moespot AJ; Fuessel S; Goettig P; Gkazepis A; Wirth MP; Schmitt M; Lossnitzer A; Sweep FC; Magdolen V
    Biol Chem; 2010 Apr; 391(4):391-401. PubMed ID: 20180634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Murine, but not human, ephrin-B2 can be efficiently cleaved by the serine protease kallikrein-4: implications for xenograft models of human prostate cancer.
    Lisle JE; Mertens-Walker I; Stephens CR; Stansfield SH; Clements JA; Herington AC; Stephenson SA
    Exp Cell Res; 2015 Apr; 333(1):136-46. PubMed ID: 25724897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of KLK4 expression and detection of KLK4-specific antibody in prostate cancer patient sera.
    Day CH; Fanger GR; Retter MW; Hylander BL; Penetrante RB; Houghton RL; Zhang X; McNeill PD; Filho AM; Nolasco M; Badaro R; Cheever MA; Reed SG; Dillon DC; Watanabe Y
    Oncogene; 2002 Oct; 21(46):7114-20. PubMed ID: 12370833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A structural model for the prostate disease marker, human prostate-specific antigen.
    Villoutreix BO; Getzoff ED; Griffin JH
    Protein Sci; 1994 Nov; 3(11):2033-44. PubMed ID: 7535613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel transcript from the KLKP1 gene is androgen regulated, down-regulated during prostate cancer progression and encodes the first non-serine protease identified from the human kallikrein gene locus.
    Kaushal A; Myers SA; Dong Y; Lai J; Tan OL; Bui LT; Hunt ML; Digby MR; Samaratunga H; Gardiner RA; Clements JA; Hooper JD
    Prostate; 2008 Mar; 68(4):381-99. PubMed ID: 18196551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Compartmentalized expression of kallikrein 4 (KLK4/hK4) isoforms in prostate cancer: nuclear, cytoplasmic and secreted forms.
    Dong Y; Bui LT; Odorico DM; Tan OL; Myers SA; Samaratunga H; Gardiner RA; Clements JA
    Endocr Relat Cancer; 2005 Dec; 12(4):875-89. PubMed ID: 16322328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostase/KLK-L1 is a new member of the human kallikrein gene family, is expressed in prostate and breast tissues, and is hormonally regulated.
    Yousef GM; Obiezu CV; Luo LY; Black MH; Diamandis EP
    Cancer Res; 1999 Sep; 59(17):4252-6. PubMed ID: 10485467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinctly different gene structure of KLK4/KLK-L1/prostase/ARM1 compared with other members of the kallikrein family: intracellular localization, alternative cDNA forms, and Regulation by multiple hormones.
    Korkmaz KS; Korkmaz CG; Pretlow TG; Saatcioglu F
    DNA Cell Biol; 2001 Jul; 20(7):435-45. PubMed ID: 11506707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Active-site specificity of digestive aspartic peptidases from the four species of Plasmodium that infect humans using chromogenic combinatorial peptide libraries.
    Beyer BB; Johnson JV; Chung AY; Li T; Madabushi A; Agbandje-McKenna M; McKenna R; Dame JB; Dunn BM
    Biochemistry; 2005 Feb; 44(6):1768-79. PubMed ID: 15697202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seminal fluid characterization for male fertility and prostate cancer: kallikrein-related serine proteases and whole proteome approaches.
    Veveris-Lowe TL; Kruger SJ; Walsh T; Gardiner RA; Clements JA
    Semin Thromb Hemost; 2007 Feb; 33(1):87-99. PubMed ID: 17253195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.